University of Alabama   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Tuscaloosa AL United States (1820)

Organization Overview

First Clinical Trial
1996
NCT00000395
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Aids Out-Ptient Clinic University of Alabama | Anesthesia Research Group UA | Comprehensive Cancer Center University of Alabama | School of Dentistry University of Alabama | The University of Alabama | University of Alabama, Birmingham, AL | University of Alabama Department of Nutrition Sciences | University of Alabama Highlands, Dept. of OB/GYN | University of Alabama Hospital | University of Alabama Medical Center | University of Alabama, Nephrology Division | University of Alabama; Rheumatologist and Healthcare Research

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 1)

Arthritis (Phase 2)

Arthritis, Experimental (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Cervical Intraepithelial Neoplasia (Phase 2)

Chronic Disease (Phase 1)

Gastroesophageal Reflux (Phase 3)

Kidney Diseases (Phase 1)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 1)

Lymphoma, Non-Hodgkin (Phase 1)

Macrophage Activation Syndrome (Phase 1)

Melanoma (Phase 2)

Neoplasms (Phase 2)

Renal Insufficiency, Chronic (Phase 1)

Squamous Intraepithelial Lesions of the Cervix (Phase 2)

Syndrome (Phase 1)

Urinary Tract Infections (Phase 3)

Uterine Cervical Dysplasia (Phase 2)

Vesico-Ureteral Reflux (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 14
  • # of Trial APIs: 22